Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences


Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences:

A live webcast of both events will be available on the "Events and Presentations" page in the "Investors" section of the Company's website at https://investors.deciphera.com/events-presentations. A replay of both webcasts will be archived on the Company's website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, New Zealand, Switzerland, Taiwan, the United Kingdom, and the United States. For more information, visit www.deciphera.com and follow us on LinkedIn and Twitter (@Deciphera).


These press releases may also interest you

at 15:23
Boehringer Ingelheim and Atlanta Braves Foundation Partner to Support Shelter Dogs in Need
Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to...

at 15:20
Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes research
One of the main roles of the spleen is to help the body's immune system fight infections. The spleen does this through producing and regulating antibodies ? antibody production is negatively affected in various conditions, including sepsis and...

at 15:02
The Inner Circle acknowledges Lee C. Ferguson, DO, FACS as a Pinnacle Lifetime Member
Prominently featured in The Inner Circle, Lee C. Ferguson, DO, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Vascular Surgeon. Dr. Ferguson, a distinguished dual board-certified vascular surgeon and endovascular...

at 15:00
NOTICE TO THE MEDIA - Government of Canada to make an announcement on palliative care
The Honourable David J. McGuinty, Member of Parliament for Ottawa South,  on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care. MP McGuinty will be available to...

at 14:43
Unveiling a Musical Revolution: Sugar Kayne Radio Set to Launch on 2nd June
Sugar Kayne Radio, an innovative internet radio station founded by Matthew Kayne, also known as DJ Sugar Kayne, is set to launch on 2nd June. Located in the heart of North West London, Sugar Kayne Radio aims to revolutionize the online music...

at 14:38
FDA Roundup: April 26, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars," by Sarah Yim,...

More news about Health...


News published on and distributed by: